BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10772600)

  • 1. Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed.
    Penk WE; Flannery RB; Irvin E; Geller J; Fisher W; Hanson MA
    J Addict Dis; 2000; 19(1):23-30. PubMed ID: 10772600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH; Kim D; Park SH; Lee HB; Chung EK
    J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.
    Herman M
    Int J Ment Health Nurs; 2004 Dec; 13(4):282-91. PubMed ID: 15660598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavior therapy for schizophrenia in patients with mild to moderate substance misuse problems.
    Naeem F; Kingdon D; Turkington D
    Cogn Behav Ther; 2005; 34(4):207-15. PubMed ID: 16498749
    [No Abstract]   [Full Text] [Related]  

  • 5. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
    Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
    Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Social competencies of persons with a dual diagnosis--literature review].
    Spiridonow K; Orzechowska Z
    Psychiatr Pol; 2007; 41(1):53-61. PubMed ID: 17494414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
    Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
    J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis and psychopharmacology of dual disorders.
    Decker KP; Ries RK
    Psychiatr Clin North Am; 1993 Dec; 16(4):703-18. PubMed ID: 8309808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid psychiatric and alcohol abuse/dependence disorders: psychosocial stress, abuse, and personal history factors of those in treatment.
    De Bernardo GL; Newcomb M; Toth A; Richey G; Mendoza R
    J Addict Dis; 2002; 21(3):43-59. PubMed ID: 12094999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study.
    Stowell RJ; Estroff TW
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1036-40. PubMed ID: 1429401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders of children living with drug-abusing, alcohol-abusing, and non-substance-abusing fathers.
    Kelley ML; Fals-Stewart W
    J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):621-8. PubMed ID: 15100569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Music therapy: a novel motivational approach for dually diagnosed patients.
    Ross S; Cidambi I; Dermatis H; Weinstein J; Ziedonis D; Roth S; Galanter M
    J Addict Dis; 2008; 27(1):41-53. PubMed ID: 18551887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
    Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.